Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
08/28/2008
Trade Name:
Zemuron
Generic or Proper Name (*):
rocuronium
Indications Studied:
Adjunct to general anesthesia
Therapeutic Category:
Anesthetic agent
Ages Studied:
0-17 years
Study #:
2
Study Type:
Safety/Pharmacokinetic/Pharmacodynamic
Study Design:
Open Label/Dose Response
No Patients:
137
No Centers:
23
No Countries:
3
BPCA(B), PREA(P):
B, P
Asian:
9
Black:
7
Other:
0
White:
120
Native Hawaiian or Pacific Islander:
1
American Indian/Alaska Native:
0
Hispanic/Latino:
0
Non-Hispanic/Non Latino:
0
-
-